Written by : Dr. Aishwarya Sarthe
January 23, 2025
The startup integrates AI with smartphone technology to provide innovative solutions for tracking patient health biomarkers, aiming to enhance payer-provider collaboration and improve care delivery.
Percipio Health, a healthcare startup specializing in remote patient monitoring, has raised $16 million in a Series A funding round.
The startup integrates artificial intelligence (AI) with smartphone technology to provide innovative solutions for tracking patient health biomarkers, aiming to enhance payer-provider collaboration and improve care delivery.
Co-founders Eric Rock and David Lucas, who previously led Vivify Health (acquired by Optum in 2019), are channeling their experience into Percipio.
Rock said,“It was an opportunity to learn how the players and providers collaborated. We found some of the opportunities for increased transparency and a technological platform that would help them facilitate a better relationship.”
Percipio’s mobile application collects key health metrics, such as blood pressure and blood oxygen levels, using smartphone cameras. It also includes tools for assessing brain health through vocal biomarkers, eliminating the need for additional medical devices. This data is processed and summarized for clinicians, enabling more efficient and informed patient care.
The Series A funding round saw participation from prominent investors, including UPMC Enterprises, Labcorp, Wave Ventures, and First Trust Capital Partners. The lead investor in the round was not disclosed. The funding will support Percipio's efforts to scale operations and further develop its capabilities in smartphone-based health monitoring.
Rock emphasized the potential impact of this financial backing, saying the funds will enable the company to expand its platform and explore additional clinical biomarkers, although specific details remain undisclosed. To date, the company has raised a total of $22 million.